Monitoring of hematopoietic chimerism by short tandem repeats, and the effect of CD selection on its sensitivity

Clinical Chemistry

Volumn 50, Issue 12, 2004, Pages 2411-2414

  Matsuda, Kazuyuki ^a   Yamauchi, Kazuyoshi ^a   Tozuka, Minoru ^b   Suzuki, Takefumi ^a   Sugano, Mitsutoshi ^a   Hidaka, Eiko ^a   Sana, Kenji ^a   Katsuyama, Tsutomu ^c  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; DNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELL SELECTION; CHIMERA; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIESIS; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SHORT TANDEM REPEAT;

ANTIGENS, CD3; BONE MARROW TRANSPLANTATION; CELL SEPARATION; DNA; FEMALE; HEMATOPOIESIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TANDEM REPEAT SEQUENCES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 9244243680     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.037580     Document Type: Article

References (23)

1. Khan F, Agarwal A, Agarwal S. Significance of chimerism in hematopietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 2004;34:1-12.
2. Jeffreys AJ, Wilson V, Thein SL. Hypervariable 'minisatellite' regions in human DNA. Nature 1985;314:67-73.
3. Jeffreys AJ, Wilson V, Thein SL. Individual-specific 'fingerprints' of human DNA. Nature 1985;316:76-9.
4. Kasai K, Nakamura Y, White R. Amplification of a variable number of tandem repeats (VNTR) locus (cMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J Forensic Sci 1990;35:1196-200.
5. Schraml E, Daxberger H, Watzinger F, Lion T. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience. Leukemia 2003;17:224-7.
6. Chalandon Y, Vischer S, Helg C, Chapuis B, Roosnek E. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience. Leukemia 2003;17:228-31.
7. Koehl U, Beck O, Esser R, Seifried E, Klingebiel T, Schwabe D, et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience. Leukemia 2003;17:232-6.
8. Kreyenberg H, Hölle W, Möhrle S, Niethammer D, Bader P. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience. Leukemia 2003;17:237-40.
9. Acquaviva C, Duval M, Mirebeau D, Bertin R, Cave H. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR fluorescence detection: the Paris-Robert Debré experience. Leukemia 2003;17:241-6.
10. Hancock JP, Goulden NJ, Oakhill A, Steward CG. Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR. Leukemia 2003;17:247-51.
11. Lion T. Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection. Leukemia 2003;17:252-4.
12. Wicki A, Malik N, Gratwohl A, Tichelli A, Meyer-Monard S, Müller H. Determination of the donor:host blood cell ratio after haematological stem cell transplant by means of semiquantitative detection of short tandem repeat polymorphisms. Swiss Med Wkly 2002;132:288-95.
13. Pindolia K, Janakiraman N, Kasten-Spotes C, Demanet C, Van Waeyenberge C, Pals G, et al. Enhanced assessment of allogeneic bone marrow transplant engraftment using automated fluorescent-based typing. Bone Marrow Transplant 1999;24:1235-41.
14. Alizadeh M, Bernard M, Danic B, Birebent B, Lapart C, Lamy T, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002;99:4618-25.
15. Furuwatari C, Yagi A, Yamagami O, Ishikawa M, Hidaka E, Ueno I, et al. A comprehensive system to explore p53 mutations. Am J Clin Pathol 1998;110:368-73.
16. Kanda Y, Chiba S, Hirai H, Sakamaki H, Iseki T, Kodera Y, et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood 2003;102:1541-7.
17. Singhal S, Powles R, Treleaven J, Kulkami S, Horton C, Mehta J. Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling. Leuk Lymphoma 1999;34:287-94.
18. Carella AM, Beltrami G, Corsetti MT. Autografting in chronic myeloid leukemia. Semin Hematol 2003;40:72-8.
19. Georges GE, Storb R. Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation. Int J Hematol 2003;77:3-14.
20. Talmadge JE. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Int Immunopharmacol 2003;3:1121-43.
21. Gilleece MH, Dazzi F. Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leuk Lymphoma 2003;44:23-8.
22. Leda M, Ladon D, Pieczonka A, Boruczkowski D, Jólkowska J, Witt M, et al. Donor lymphocyte infusion followed by interferon-α plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leuk Res 2001;25:353-7.
23. Gardiner N, Lawler M, O'Riordan JM, Duggan C, De Arce M, McCann SR, et al. Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukemia. Bone Marrow Transplant 1998;21:711-9.